Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · June 10, 2023

Assessment of Tyrosine Kinase Inhibitor Use and Survival and Cardiovascular Outcomes in Patients With NSCLC in Taiwan

JAMA Network Open

 

Additional Info

JAMA Network Open
Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non-Small Cell Lung Cancer in Taiwan
JAMA Netw Open 2023 May 01;6(5)e2313824, WT Chang, HW Lin, TC Chang, SH Lin, YH Li

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading